Literature DB >> 2675836

New products in the hepoxilin pathway: isolation of 11-glutathionyl hepoxilin A3 through reaction of hepoxilin A3 with glutathione S-transferase.

C R Pace-Asciak1, O Laneuville, M Chang, C C Reddy, W G Su, E J Corey.   

Abstract

We describe herein the metabolism of hepoxilin A3 (HxA3) by glutathione S-transferase (GST) into a glutathione conjugate. The reaction was carried out with HxA3 (unlabelled and 14C-labelled) and glutathione (unlabelled and tritium labelled). When two isomers of HxA3 were reacted with GST, two products were formed. Only one product was formed when a single isomer of HxA3 was used. The isomeric product HxB3 was marginally active indicating considerable specificity in the reaction with GST. The products were characterized by retention of tritium from glutathione and by comparison of their migration on high performance liquid chromatography with authentic reference compounds. The products bear the structure, 11-glutathionyl HxA3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675836     DOI: 10.1016/0006-291x(89)91109-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils.

Authors:  Asa Brunnström; Mats Hamberg; William J Griffiths; Bengt Mannervik; Hans-Erik Claesson
Journal:  Lipids       Date:  2010-10-29       Impact factor: 1.880

Review 2.  Hepoxilins: a review on their enzymatic formation, metabolism and chemical synthesis.

Authors:  C R Pace-Asciak; D Reynaud; P M Demin
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

3.  Hepoxilin A3-specific binding in human neutrophils.

Authors:  D Reynaud; P Demin; C R Pace-Asciak
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

4.  A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system.

Authors:  C R Pace-Asciak; O Laneuville; W G Su; E J Corey; N Gurevich; P Wu; P L Carlen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.